The National Cancer Institute (NCI) is offering this grant to support institutions/organizations in maintaining a Canadian Collaborating Clinical Trials Network. This grant is for establishing and sustaining a robust Canadian partner for the NCI National Clinical Trials Network (NCTN). The Canadian Collaborating Clinical Trials Network will serve as a full collaborator with the U.S. Network, playing a crucial role in the conduct of large-scale, multi-site clinical trials. Additionally, it will provide essential regulatory expertise and oversight for all NCTN trials conducted within Canada. This initiative aims to strengthen international collaboration in cancer research and enhance the efficiency and reach of clinical trials.
Opportunity ID: 356682
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-032 |
| Funding Opportunity Title: | Single Source: NCI National Clinical Trials Network – Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 10, 2024 |
| Last Updated Date: | Oct 10, 2024 |
| Original Closing Date for Applications: | Feb 24, 2025 |
| Current Closing Date for Applications: | Feb 24, 2025 |
| Archive Date: | Apr 01, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Regional Organizations; Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain a Canadian Collaborating Clinical Trials Network for the NCI National Clinical Trials Network (NCTN). The NCTN Canadian Collaborating Clinical Trials Network will be a full partner with the U.S. Network in the conduct of large-scale, multi-site clinical trials and help provide regulatory expertise/oversight for the conduct of NCTN trials in Canada. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-032.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 356682 Full Announcement-RFA-CA-24-032 -> RFA-CA-24-032-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00288085 | Jan 24, 2025 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289342 | Jan 24, 2025 | Feb 24, 2025 | View |
Package 1
Mandatory forms
356682 RR_SF424_5_0-5.0.pdf
356682 PHS398_CoverPageSupplement_5_0-5.0.pdf
356682 RR_OtherProjectInfo_1_4-1.4.pdf
356682 PerformanceSite_4_0-4.0.pdf
356682 RR_KeyPersonExpanded_4_0-4.0.pdf
356682 PHS398_ResearchPlan_5_0-5.0.pdf
356682 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356682 PHS_Additional_IndirectCosts_2_0-2.0.pdf
356682 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
356682 RR_SF424_5_0-5.0.pdf
356682 PHS398_CoverPageSupplement_5_0-5.0.pdf
356682 RR_OtherProjectInfo_1_4-1.4.pdf
356682 PerformanceSite_4_0-4.0.pdf
356682 RR_KeyPersonExpanded_4_0-4.0.pdf
356682 PHS398_ResearchPlan_5_0-5.0.pdf
356682 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356682 PHS_Additional_IndirectCosts_2_0-2.0.pdf
356682 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
